Management of<unk>  nephropathy is not separate from that of overall patient management. In addition, however, the use of ACE inhibitors has been associated with improvement of the hyperfiltration glomerulopathy. Three-year graft and patient survival in kidney transplant recipients with<unk>  nephropathy is lower when compared to those with other causes of end-stage kidney disease.
Sickle cell nephropathy
IgA nephropathy
Malarial nephropathy
Analgesic nephropathy
Mesoamerican nephropathy
Phosphate nephropathy
Uddanam nephropathy
Membranous glomerulonephritis